Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
Year: 2010
Type: review
Source: Seminars in Oncology
Authors: Axel Hoos, Ramy Ibrahim, Alan Korman, Kald Abdallah, David Berman, Vafa Shahabi, Kevin Chin, Renzo Canetta, Rachel Humphrey
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bristol-Myers Squibb
OpenAlex ID: W2055175265
